Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Antibody Contract Manufacturing Market Size Likely To Evolve From 2025 Through 2034?
The antibody contract manufacturing market has experienced rapid expansion in its size over recent years. Projections indicate it will expand from $14.8 billion in 2024 to reach $16.79 billion by 2025, reflecting a compound annual growth rate (CAGR) of 13.4%. This historical growth can be linked to several factors, including the rising demand for monoclonal antibodies, a transition towards personalized medicine, efforts in cost optimization, strict regulatory requirements, and the globalization of biologics.
The antibody contract manufacturing market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $29.79 billion by 2029, demonstrating a robust compound annual growth rate (CAGR) of 15.4%. This projected growth throughout the forecast period stems from several factors, including increasing r&d spending, expansion of bispecific and multispecific antibodies, the rise of antibody-drug conjugates (adcs), increasing healthcare infrastructure, and growing government initiatives. Key developments anticipated during this period encompass digitalization and data analytics, advanced upstream technologies, novel downstream processing techniques, sustainability initiatives, and contract development and manufacturing integration (CDMO).
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12665&type=smp
What Are The Main Drivers Boosting The Antibody Contract Manufacturing Industry’s Expansion?
The growing volume of clinical trials is anticipated to drive the expansion of the antibody contract manufacturing market moving forward. These trials are research studies conducted with human participants to assess the safety and efficacy of novel medical treatments, interventions, or diagnostic methods. As the number of clinical trials involving antibody-based therapeutics or diagnostics increases, there is a greater need for high-quality antibodies, ensuring a timely and compliant supply for these trials. For instance, in May 2023, data from ClinicalTrials.gov, a component of the National Institutes of Health (NIH), a US-based government agency responsible for medical research, indicated an increase in registered clinical trial studies across all 50 states of the United States and 221 countries. The count rose from 399,499 in 2022 to 437,533 in 2023. Furthermore, approximately 241,498 studies, representing 53% of the total, were registered outside the United States, compared to 140,492 studies (31%) registered solely within the United States. Therefore, the increasing number of clinical trials is a significant factor propelling the growth of the antibody contract manufacturing market.
What Are The Primary Types Of Segments Analyzed In The Antibody Contract Manufacturing Market?
The antibody contract manufacturingmarket covered in this report is segmented –
1) By Product: Monoclonal Antibodies; Polyclonal Antibodies; Other Products
2) By Source: Mammalian; Microbial
3) Scale Of Operation: Preclinical; Clinical; Commercial
4) By End-User: Biopharmaceutical Companies; Research Laboratories; Other End Users
Subsegments:
1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies; Diagnostic Monoclonal Antibodies
2) By Polyclonal Antibodies: Research Polyclonal Antibodies; Therapeutic Polyclonal Antibodies
3) By Other Products: Bispecific Antibodies; Antibody-Drug Conjugates (ADCs); Fusion Proteins
Which Competitive Trends Are Defining The Antibody Contract Manufacturing Market Structure?
Major companies operating in the antibody contract manufacturing market are concentrating on innovations like single-use technology, which minimizes cross-contamination risks and lowers operational costs. Single-use technology (SUT) encompasses disposable components and systems utilized in biopharmaceutical manufacturing processes. As an illustration, in September 2024, US-based pharmaceutical company Merck & Co. unveiled the Mobius ADC Reactor, engineered to improve the production of antibody-drug conjugates. This novel single-use reactor, purpose-built for antibody drug conjugate manufacturing, notably boosts production efficiency by 70% compared to conventional stainless steel or glass techniques. Its disposable nature reduces cross-contamination risks and operational expenditures, facilitating quicker turnaround times. Moreover, advanced film technology enhances bag strength and leak resistance, thereby safeguarding the integrity of highly potent active pharmaceutical ingredients. Such innovation aids biopharmaceutical companies in manufacturing essential therapies with greater safety and efficiency.
Who Are The Prominent Global Companies Shaping The Antibody Contract Manufacturing Market?
Major companies operating in the antibody contract manufacturing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., AGC Biologics S.p.A.
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Antibody Contract Manufacturing Industry?
North America was the largest region in the antibody contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Antibody Contract Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12665&type=smp
Browse Through More Reports Similar to the Global Antibody Contract Manufacturing Market 2025, By The Business Research Company
Antibody Drug Conjugates Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Contract Development Manufacturing Organizations Global Market Report 2025
Manufacturing Execution System Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model